STOCK TITAN

[Form 4] American Vanguard Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Marisol Angelini, a director of American Vanguard Corp (AVD), reported on Form 4 that she was awarded 17,621 shares of common stock on 08/07/2025 as part of the companys compensation program for non-management directors related to the 2025 annual stockholders meeting. The award is reported at a price of $0 in the filing and is explained in an accompanying footnote.

Following the award, Angelini beneficially owns 36,890 shares. The Form 4 was signed on 08/08/2025 and filed by one reporting person. No derivative transactions are listed in Table II.

Marisol Angelini, membro del consiglio di American Vanguard Corp (AVD), ha dichiarato nel Form 4 di aver ricevuto 17.621 azioni ordinarie in data 08/07/2025 come parte del programma di compenso per i direttori non esecutivi relativo all'assemblea annuale degli azionisti 2025. L'assegnazione è riportata nel deposito a un prezzo di $0 e viene spiegata in una nota a piè di pagina.

Dopo l'assegnazione, Angelini detiene in via beneficiaria 36.890 azioni. Il Form 4 è stato firmato il 08/08/2025 ed è stato presentato da un unico soggetto obbligato a riportare. Nella Tabella II non sono elencate transazioni su strumenti derivati.

Marisol Angelini, directora de American Vanguard Corp (AVD), informó en el Form 4 que se le adjudicaron 17.621 acciones ordinarias el 08/07/2025 como parte del programa de compensación para directores no ejecutivos vinculado a la junta anual de accionistas de 2025. La adjudicación figura en la presentación a un precio de $0 y se explica en una nota al pie adjunta.

Tras la adjudicación, Angelini posee de forma beneficiaria 36.890 acciones. El Form 4 fue firmado el 08/08/2025 y presentado por una sola persona informante. En la Tabla II no se listan transacciones sobre derivados.

Marisol AngeliniAmerican Vanguard Corp (AVD)의 이사로서 Form 4에 비경영 이사 보상 프로그램의 일환으로 2025년 8월 7일에 보통주 17,621주를 수여받았다고 보고했습니다. 제출서류에는 이 수여가 $0로 보고되어 있으며 부속 주석에서 설명하고 있습니다.

수여 후 Angelini는 실질적으로 36,890주를 보유하게 됩니다. Form 4는 2025년 8월 8일에 서명되었고 한 명의 보고자가 이를 제출했습니다. 표 II에는 파생상품 거래가 기재되어 있지 않습니다.

Marisol Angelini, administratrice de American Vanguard Corp (AVD), a déclaré dans le Form 4 qu'elle a reçu 17.621 actions ordinaires le 08/07/2025 dans le cadre du programme de rémunération des administrateurs non exécutifs lié à l'assemblée générale annuelle 2025. L'attribution est déclarée dans le dépôt à un prix de $0 et est expliquée dans une note de bas de page jointe.

Après l'attribution, Angelini détient à titre bénéficiaire 36.890 actions. Le Form 4 a été signé le 08/08/2025 et déposé par une seule personne déclarente. Aucune transaction sur dérivés n'apparaît dans le Tableau II.

Marisol Angelini, Direktorin von American Vanguard Corp (AVD), gab im Form 4 an, dass ihr am 08/07/2025 im Rahmen des Vergütungsprogramms für nicht geschäftsführende Direktoren im Zusammenhang mit der Hauptversammlung 2025 17.621 Stammaktien zugewiesen wurden. Die Zuweisung wird in der Einreichung zu einem Preis von $0 angegeben und in einer beigefügten Fußnote erläutert.

Nach der Zuweisung besitzt Angelini wirtschaftlich 36.890 Aktien. Das Form 4 wurde am 08/08/2025 unterzeichnet und von einer meldenden Person eingereicht. In Tabelle II sind keine derivative Transaktionen aufgeführt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director received an equity award of 17,621 shares as non-management director compensation, increasing reported beneficial ownership to 36,890 shares.

The Form 4 discloses a stock award granted under the companys non-management director compensation program, reported at a $0 price and documented with a footnote linking it to the 2025 annual meeting. This is a standard disclosure of insider ownership change by a director; it provides transparency on board member equity stakes but does not itself indicate any change in board composition or corporate control from the information provided.

TL;DR: A 17,621-share award was recorded with no cash consideration; no derivatives or additional transactions were reported.

Table I shows an acquisition (code A) of 17,621 common shares with price reported as $0, increasing beneficial holdings to 36,890 shares. Table II contains no derivative entries. The filing is limited to an equity award to a director and does not disclose other transactions, amendments, or material financing activity.

Marisol Angelini, membro del consiglio di American Vanguard Corp (AVD), ha dichiarato nel Form 4 di aver ricevuto 17.621 azioni ordinarie in data 08/07/2025 come parte del programma di compenso per i direttori non esecutivi relativo all'assemblea annuale degli azionisti 2025. L'assegnazione è riportata nel deposito a un prezzo di $0 e viene spiegata in una nota a piè di pagina.

Dopo l'assegnazione, Angelini detiene in via beneficiaria 36.890 azioni. Il Form 4 è stato firmato il 08/08/2025 ed è stato presentato da un unico soggetto obbligato a riportare. Nella Tabella II non sono elencate transazioni su strumenti derivati.

Marisol Angelini, directora de American Vanguard Corp (AVD), informó en el Form 4 que se le adjudicaron 17.621 acciones ordinarias el 08/07/2025 como parte del programa de compensación para directores no ejecutivos vinculado a la junta anual de accionistas de 2025. La adjudicación figura en la presentación a un precio de $0 y se explica en una nota al pie adjunta.

Tras la adjudicación, Angelini posee de forma beneficiaria 36.890 acciones. El Form 4 fue firmado el 08/08/2025 y presentado por una sola persona informante. En la Tabla II no se listan transacciones sobre derivados.

Marisol AngeliniAmerican Vanguard Corp (AVD)의 이사로서 Form 4에 비경영 이사 보상 프로그램의 일환으로 2025년 8월 7일에 보통주 17,621주를 수여받았다고 보고했습니다. 제출서류에는 이 수여가 $0로 보고되어 있으며 부속 주석에서 설명하고 있습니다.

수여 후 Angelini는 실질적으로 36,890주를 보유하게 됩니다. Form 4는 2025년 8월 8일에 서명되었고 한 명의 보고자가 이를 제출했습니다. 표 II에는 파생상품 거래가 기재되어 있지 않습니다.

Marisol Angelini, administratrice de American Vanguard Corp (AVD), a déclaré dans le Form 4 qu'elle a reçu 17.621 actions ordinaires le 08/07/2025 dans le cadre du programme de rémunération des administrateurs non exécutifs lié à l'assemblée générale annuelle 2025. L'attribution est déclarée dans le dépôt à un prix de $0 et est expliquée dans une note de bas de page jointe.

Après l'attribution, Angelini détient à titre bénéficiaire 36.890 actions. Le Form 4 a été signé le 08/08/2025 et déposé par une seule personne déclarente. Aucune transaction sur dérivés n'apparaît dans le Tableau II.

Marisol Angelini, Direktorin von American Vanguard Corp (AVD), gab im Form 4 an, dass ihr am 08/07/2025 im Rahmen des Vergütungsprogramms für nicht geschäftsführende Direktoren im Zusammenhang mit der Hauptversammlung 2025 17.621 Stammaktien zugewiesen wurden. Die Zuweisung wird in der Einreichung zu einem Preis von $0 angegeben und in einer beigefügten Fußnote erläutert.

Nach der Zuweisung besitzt Angelini wirtschaftlich 36.890 Aktien. Das Form 4 wurde am 08/08/2025 unterzeichnet und von einer meldenden Person eingereicht. In Tabelle II sind keine derivative Transaktionen aufgeführt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Angelini Marisol

(Last) (First) (Middle)
4695 MACARTHUR COURT, STE 1200

(Street)
NEWPORT BEACH CA 92660

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AMERICAN VANGUARD CORP [ AVD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/07/2025 A 17,621(1) A $0 36,890 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares were awarded as part of the Company's compensation program for non-management directors in connection with the 2025 annual stockholders' meeting.
/s/ MARISOL ANGELINI 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Marisol Angelini report on the AVD Form 4?

On 08/07/2025, Marisol Angelini reported an award of 17,621 shares of American Vanguard Corp common stock at a reported price of $0.

How many AVD shares does Marisol Angelini beneficially own after the reported transaction?

Following the reported award, Angelini beneficially owns 36,890 shares.

Was the AVD Form 4 filed by multiple reporting persons?

No. The form indicates it was filed by one reporting person.

When was the Form 4 signed?

The Form 4 carries the reporting person's signature dated 08/08/2025.

Does the AVD Form 4 report any derivative transactions for Angelini?

No. Table II lists no derivative securities acquired or disposed of in this filing.
American Vanguard Corp

NYSE:AVD

AVD Rankings

AVD Latest News

AVD Latest SEC Filings

AVD Stock Data

149.26M
25.71M
8.31%
70.42%
1.99%
Agricultural Inputs
Agricultural Chemicals
Link
United States
NEWPORT BEACH